Patient self-testing of white blood cell count and differentiation: A study of feasibility and measurement performance in a population of Danish cancer patients
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
Patient self-testing of white blood cell count and differentiation : A study of feasibility and measurement performance in a population of Danish cancer patients. / Otto Mattsson, Thea; Lindhart, Christina Louise; Schöley, Jonas; Friis-Hansen, Lennart; Herrstedt, Jørn.
I: European Journal of Cancer Care, Bind 29, Nr. 1, e13189, 2020.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Patient self-testing of white blood cell count and differentiation
T2 - A study of feasibility and measurement performance in a population of Danish cancer patients
AU - Otto Mattsson, Thea
AU - Lindhart, Christina Louise
AU - Schöley, Jonas
AU - Friis-Hansen, Lennart
AU - Herrstedt, Jørn
N1 - Publisher Copyright: © 2019 John Wiley & Sons Ltd
PY - 2020
Y1 - 2020
N2 - Objective: Patients in anticancer treatment with a known side effect of neutropenia are monitored closely with laboratory measurements of white blood cell count (WBC) and differentiation. This study sought to evaluate measurement properties and feasibility of patients' self-testing using a point-of-care testing (POCT) device. Methods: A prospective feasibility and measurement study comparing the standard measurement of cancer patients' WBC and neutrophil count with POCT measurements. The study included 60 outpatients and 22 inpatients from a department of oncology at a university hospital. Results: Patients successfully conducted 106 measurements using the POCT device. 46% of the patients were >70 years. Weighted Deming regression analysis showed minimal yet significant proportional bias between methods, with POCT increasingly underestimating both total WBC and neutrophils compared with the standard method the higher the count. Over 90% of patients reported they were willing and considered themselves able to use the POCT device at home. Conclusions: The instrument can be used for self-testing of post-anticancer leukopenia and has sufficient measurement precision for patient risk stratification. Patients are able and willing to conduct measurements including when in a situation of acute illness. Further studies are needed to confirm safety and value within patients’ own home.
AB - Objective: Patients in anticancer treatment with a known side effect of neutropenia are monitored closely with laboratory measurements of white blood cell count (WBC) and differentiation. This study sought to evaluate measurement properties and feasibility of patients' self-testing using a point-of-care testing (POCT) device. Methods: A prospective feasibility and measurement study comparing the standard measurement of cancer patients' WBC and neutrophil count with POCT measurements. The study included 60 outpatients and 22 inpatients from a department of oncology at a university hospital. Results: Patients successfully conducted 106 measurements using the POCT device. 46% of the patients were >70 years. Weighted Deming regression analysis showed minimal yet significant proportional bias between methods, with POCT increasingly underestimating both total WBC and neutrophils compared with the standard method the higher the count. Over 90% of patients reported they were willing and considered themselves able to use the POCT device at home. Conclusions: The instrument can be used for self-testing of post-anticancer leukopenia and has sufficient measurement precision for patient risk stratification. Patients are able and willing to conduct measurements including when in a situation of acute illness. Further studies are needed to confirm safety and value within patients’ own home.
KW - aged
KW - antineoplastic agents
KW - febrile neutropenia
KW - medical oncology
KW - patient comfort
KW - patient education
KW - point-of-care testing
UR - http://www.scopus.com/inward/record.url?scp=85075201182&partnerID=8YFLogxK
U2 - 10.1111/ecc.13189
DO - 10.1111/ecc.13189
M3 - Journal article
C2 - 31746087
AN - SCOPUS:85075201182
VL - 29
JO - European Journal of Cancer Care
JF - European Journal of Cancer Care
SN - 0961-5423
IS - 1
M1 - e13189
ER -
ID: 269909470